Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
CARPROFEN
Pfizer Healthcare Ireland
QM01AE91
50 Mg/Ml
Solution for Injection
N.S.A.I.D
Bovine
1996-12-13
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rimadyl 50 mg/ml solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for injection. A clear, pale straw coloured liquid. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Young cattle (under 12 months of age) and equines. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Rimadyl Solution is indicated as adjunctive therapy for the control of acute inflammation associated with respiratory disease in young cattle (under 12 months of age). The cause of the condition should be determined and treated with an appropriate antimicrobial. In horses and ponies, it is indicated for analgesic and anti-inflammatory action in musculo-skeletal disorders and after surgery. 4.3 CONTRAINDICATIONS Do not exceed the stated dose or the duration of treatment. Do not use in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product. Do not administer other NSAIDs concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE Each ml of product contains: Active substance Caprofen 50 mg Excipients Ethanol 0.1 ml For a full list of excipients, see section 6.1 IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 12/10/2010_ _CRN 7007518_ _page number: 1_ SPECIAL PRECAUTION(S) FOR USE IN ANIMALS Use in any animal less than 6 weeks of age may involve additional risk Lees het volledige document